Terry, P., Vainio, H., Wolk, A., and Weiderpass, E. Dietary factors in relation to endometrial cancer: a nationwide case-control study in Sweden. Nutr Cancer 2002;42(1):25-32. View abstract.
Thamsborg, G., Jensen, J. E., Kollerup, G., Hauge, E. M., Melsen, F., and Sorensen, O. H. Effect of nasal salmon calcitonin on bone remodeling and bone mass in postmenopausal osteoporosis. Bone 1996;18(2):207-212. View abstract.
Thamsborg, G., Storm, T. L., Sykulski, R., Brinch, E., Nielsen, H. K., and Sorensen, O. H. Effect of different doses of nasal salmon calcitonin on bone mass. Calcif Tissue Int 1991;48(5):302-307. View abstract.
The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I. JAMA 3-4-1992;267(9):1213-1220. View abstract.
Theobald GW. Effect of calcium and vitamins A and D on incidence of pregnancy toxemia. Lancet 1937;1:1397-1399.
Thomas, M. G., Thomson, J. P., and Williamson, R. C. Oral calcium inhibits rectal epithelial proliferation in familial adenomatous polyposis. Br.J Surg. 1993;80(4):499-501. View abstract.
Thomsen, K., Nilas, L., and Christiansen, C. Dietary calcium intake and blood pressure in normotensive subjects. Acta Med.Scand. 1987;222(1):51-56. View abstract.
Yimdjo, M. C., Azebaze, A. G., Nkengfack, A. E., Meyer, A. M., Bodo, B., and Fomum, Z. T. Antimicrobial and cytotoxic agents from Calophyllum inophyllum. Phytochemistry 2004;65(20):2789-2795. View abstract.
De Clercq, E. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med.Res Rev. 2000;20(5):323-349. View abstract.
Adeyeye, A. Studies on seed oils of Garcinia kola and Calophyllum inophyllum. Journal Of The Science Of Food And Agriculture 1991;57(3):441-442.
Boyer PL, Currens MH, McMahon JB. Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase. J Virol 1993;67:2412-20. View abstract.
Buckheit RW, White EL, Fliakas-Boltz V, et al. Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide. Antimicrob Agents Chemother 1999;43:1827-34. View abstract.
Currens MJ, Gulakowski RJ, Mariner JM, et al. Antiviral activity and mechanism of action of calanolide A against the human immunodeficiency virus type-1. J Pharmacol Exp Ther 1996;279:645-51. View abstract.
Currens MJ, Nariner JM, McMahon JB, Boyd MR. Kinetic analysis of inhibition of human immunodeficiency virus type-a reverse transcriptase by calanolide A. J Pharmacol Exp Ther 1996;279:652-61. View abstract.
Hemavathy, J. and Prabhakar, J. V. Lipid composition of Calophyllum inophyllum kernel. Journal Of The American Oil Chemists' Society 1990;67(12):955-957.
Itoigawa, M., Ito, C., Tan, H. T., Kuchide, M., Tokuda, H., Nishino, H., and Furukawa, H. Cancer chemopreventive agents, 4-phenylcoumarins from Calophyllum inophyllum. Cancer Lett. 8-10-2001;169(1):15-19. View abstract.
Laure, F., Herbette, G., Faure, R., Bianchini, J. P., Raharivelomanana, P., and Fogliani, B. Structures of new secofriedelane and friedelane acids from Calophyllum inophyllum of French Polynesia. Magn Reson.Chem 2005;43(1):65-68. View abstract.
Le Coz, C. J. Allergic contact dermatitis from tamanu oil (Calophyllum inophyllum, Calophyllum tacamahaca). Contact Dermatitis 2004;51(4):216-217. View abstract.
Newman RA, Chen W, Madden TL. Pharmaceutical properties of related calanolide compounds with activity against human immunodeficiency virus. J Pharm Sci 1998;87:1077-80. View abstract.
Oku, H., Ueda, Y., Iinuma, M., and Ishiguro, K. Inhibitory effects of xanthones from guttiferae plants on PAF-induced hypotension in mice. Planta Med 2005;71(1):90-92. View abstract.
Patil, A. D., Freyer, A. J., Eggleston, D. S., Haltiwanger, R. C., Bean, M. F., Taylor, P. B., Caranfa, M. J., Breen, A. L., Bartus, H. R., Johnson, R. K., and . The inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree, Calophyllum inophyllum Linn. J Med Chem 12-24-1993;36(26):4131-4138. View abstract.
Pillai, S. N., Desai, M. V., and Shah, H. M. Antihelminthic properties of Punnakkai Cake (Calophyllum inophyllum). Indian J Mycol Plant Path 1974;4(145):150.
Potti, G. R. and Kurup, P. A. Antibacterial principle of the root bark of Calophyllum inophyllum: isolation and antibacterial activity. Indian J Exp.Biol. 1970;8(1):39-40. View abstract.
Protocol Title: A Phase 1B Dose-Range Study to Evaluate the Safety, Pharmacokinetics, and Effects of (+)-calaonlide A on surrogate markers in HIV-positive patients with no previous antiretroviral therapy. Protocol ID numbers: FDA 297A.
Reuters Health. Anti-HIV herbal product shows therapeutic potential in phase I trial. November 1, 1999.
Sekino, E., Kumamoto, T., Tanaka, T., Ikeda, T., and Ishikawa, T. Concise synthesis of anti-HIV-1 active (+)-inophyllum B and (+)-calanolide A by application of (-)-quinine-catalyzed intramolecular oxo-Michael addition. J Org Chem 4-16-2004;69(8):2760-2767. View abstract.
Spino, C., Dodier, M., and Sotheeswaran, S. Anti-HIV coumarins from Calophyllum seed oil. Bioorg.Med Chem Lett. 12-15-1998;8(24):3475-3478. View abstract.
Taylor, P. B., Culp, J. S., Debouck, C., Johnson, R. K., Patil, A. D., Woolf, D. J., Brooks, I., and Hertzberg, R. P. Kinetic and mutational analysis of human immunodeficiency virus type 1 reverse transcriptase inhibition by inophyllums, a novel class of non-nucleoside inhibitors. J Biol.Chem 3-4-1994;269(9):6325-6331. View abstract.